Close this search box.

We are creating some awesome events for you. Kindly bear with us.

Monash University Develops World-first in Imaging Tech

Magnetic Particle Imaging (MPI) is a new non-invasive molecular imaging technique that offers significantly increased tracer sensitivity over MRI and remarkably faster acquisition times than nuclear medicine, opening the door to cutting edge opportunities for interdisciplinary projects in medical research, chemistry and biotechnology.

It detects iron oxide nanoparticles to produce 2D and 3D images. MPI imaging is more sensitive and significantly faster than MRI and PET imaging.

Working synergistically together, these three technologies (MPI, MRI, PET) offer a preclinical theranostic platform that delivers exceptional image quality to detect and treat therapeutic targets.

Benefits of MPI 

  • The Magnetic Insight system currently offers the world’s highest sensitivity and resolution of MPI images
  • Simple to operate, eliminating the need for a dedicated scanner operator and allowing researchers to acquire their own data
  • Avoids the radiation burden of PET, and when used without CT removes the x-ray dose

The new technology was funded through an ARC LIEF grant with contributions from Monash University and RMIT, and combines Magnetic Particle Imaging (MPI) with Computed Tomography (CT) and Hyperthermia capabilities for preclinical, in vivo research.

It is located at the Monash Alfred campus and is operated by the Alfred Research Alliance-Monash Biomedical Imaging (ARA-MBI) platform.

The preclinical Momentum™ MPI system, developed by Magnetic Insight, is the world’s first MPI system with CT and Hyperthermia capabilities. The technology quantitatively detects magnetic nanoparticles anywhere in the body with exceptional sensitivity, enabling researchers the ability to track the nanoparticles in vivo, where they can bind to particular cells of interest.

Using the same in vivo living subject, the Hyperthermia technology can then define an area with pinpoint accuracy and induce localised heating in this area up to a desired therapeutic temperature designed to kill the cells that have been bound with the nanoparticles.

The capabilities can also monitor chemotherapy treatments and enhance their efficacy with the addition of targeted heating. “With just 0.01% of chemotherapy currently reaching the cancer tissue, it is so important to boost the potency of the drugs reaching the target,” said Dr Karen Alt, Head of the Nano Theranostics Laboratory at the Australian Centre for Blood Diseases, Monash University.

Associate Professor Christoph Hagemeyer, Head of the NanoBiotechnology Laboratory at the Australian Centre for Blood Diseases, Monash University said that MPI and targeted Hyperthermia are seen as the most promising new developments in the non-invasive diagnostic imaging and therapy field in decades as it combines the non-invasive nature of MRI with the sensitivity of PET, thereby unifying the best from two mainstream clinical modalities.

The ARA-MBI Platform offers preclinical researchers access to the latest imaging equipment integrating high-resolution imaging and diagnostics to inform personalised therapeutic targets. The technologies include Magnetic Resonance Imaging (MRI), MPI and Positron Emission Tomography (PET)/CT scanners.

Monash and its collaborators are world leaders in advanced nanoparticle fabrication, which is critical to MPI reaching its full potential. This is because MPI resolution and sensitivity are driven as much by the magnetic tracer’s properties as by the imaging hardware.

The facility will be used to develop specialised iron oxide nanoparticles with the highest MPI sensitivity and responsiveness, enabling new opportunities for research in critical research fields such as vaccine technology development.

An expert in Magnetic Particle Imaging (MPI) technology and co-founder and CEO of Magnetic Insight added that the team has been working with an Australian SME to deliver and support this ground-breaking technology.

The facility will further enhance Monash’s leadership in advanced materials science nanotechnology, molecular imaging and biosciences, the Academic Director, Research Infrastructure at Monash University said.


Qlik’s vision is a data-literate world, where everyone can use data and analytics to improve decision-making and solve their most challenging problems. A private company, Qlik offers real-time data integration and analytics solutions, powered by Qlik Cloud, to close the gaps between data, insights and action. By transforming data into Active Intelligence, businesses can drive better decisions, improve revenue and profitability, and optimize customer relationships. Qlik serves more than 38,000 active customers in over 100 countries.


As a Titanium Black Partner of Dell Technologies, CTC Global Singapore boasts unparalleled access to resources.

Established in 1972, we bring 52 years of experience to the table, solidifying our position as a leading IT solutions provider in Singapore. With over 300 qualified IT professionals, we are dedicated to delivering integrated solutions that empower your organization in key areas such as Automation & AI, Cyber Security, App Modernization & Data Analytics, Enterprise Cloud Infrastructure, Workplace Modernization and Professional Services.

Renowned for our consulting expertise and delivering expert IT solutions, CTC Global Singapore has become the preferred IT outsourcing partner for businesses across Singapore.


Planview has one mission: to build the future of connected work. Our solutions enable organizations to connect the business from ideas to impact, empowering companies to accelerate the achievement of what matters most. Planview’s full spectrum of Portfolio Management and Work Management solutions creates an organizational focus on the strategic outcomes that matter and empowers teams to deliver their best work, no matter how they work. The comprehensive Planview platform and enterprise success model enables customers to deliver innovative, competitive products, services, and customer experiences. Headquartered in Austin, Texas, with locations around the world, Planview has more than 1,300 employees supporting 4,500 customers and 2.6 million users worldwide. For more information, visit


SIRIM is a premier industrial research and technology organisation in Malaysia, wholly-owned by the Minister​ of Finance Incorporated. With over forty years of experience and expertise, SIRIM is mandated as the machinery for research and technology development, and the national champion of quality. SIRIM has always played a major role in the development of the country’s private sector. By tapping into our expertise and knowledge base, we focus on developing new technologies and improvements in the manufacturing, technology and services sectors. We nurture Small Medium Enterprises (SME) growth with solutions for technology penetration and upgrading, making it an ideal technology partner for SMEs.


HashiCorp provides infrastructure automation software for multi-cloud environments, enabling enterprises to unlock a common cloud operating model to provision, secure, connect, and run any application on any infrastructure. HashiCorp tools allow organizations to deliver applications faster by helping enterprises transition from manual processes and ITIL practices to self-service automation and DevOps practices. 


IBM is a leading global hybrid cloud and AI, and consulting services provider, helping clients in more than 175 countries capitalize on insights from their data, streamline business processes, reduce costs and gain the competitive edge in their industries. Nearly 3,800 government and corporate entities in critical infrastructure areas such as financial services, telecommunications and healthcare rely on IBM’s hybrid cloud platform and Red Hat OpenShift to affect their digital transformations quickly, efficiently, and securely. IBM’s breakthrough innovations in AI, quantum computing, industry-specific cloud solutions and business services deliver open and flexible options to our clients. All of this is backed by IBM’s legendary commitment to trust, transparency, responsibility, inclusivity, and service. For more information, visit